Clinical Trial Update: Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Phase 1]

View source ↗

Summary

A Phase I study of temozolomide combined with O6-benzylguanine and irinotecan in patients with recurrent or progressive cerebral anaplastic gliomas, including g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Camptosar (irinotecan)
• O6-Benzylguanine (O6-Benzylguanine)
• Temodar (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma, Gliosarcoma | Phase 1 | Status: COMPLETED